JPH10175989A - Para-aminobenzoic acid glycoside, its production and preparation containing the same as active ingredient - Google Patents

Para-aminobenzoic acid glycoside, its production and preparation containing the same as active ingredient

Info

Publication number
JPH10175989A
JPH10175989A JP8333465A JP33346596A JPH10175989A JP H10175989 A JPH10175989 A JP H10175989A JP 8333465 A JP8333465 A JP 8333465A JP 33346596 A JP33346596 A JP 33346596A JP H10175989 A JPH10175989 A JP H10175989A
Authority
JP
Japan
Prior art keywords
para
aminobenzoic acid
medium
eucalyptus
glycoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8333465A
Other languages
Japanese (ja)
Inventor
Tsutomu Furuya
力 古谷
Yoichi Matsuura
洋一 松浦
Satoshi Mizobata
聡 溝端
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP8333465A priority Critical patent/JPH10175989A/en
Publication of JPH10175989A publication Critical patent/JPH10175989A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a new para-aminobenzoic acid glycoside excellent in water solubility and useful for ultraviolet light absorbents, medicines, cosmetics, etc., without passing through complicated synthesis processes. SOLUTION: A compound of formula I or II [R is H, glucose reside (1→6)]. For example, para-aminobenzoyl β-D-glucopyranoside. The compound of formula I or II is obtained by culturing culture cells derived from the tissue piece of a Eucalyptus plant such as Eucalyptus perriniana, adding para-aminobenzoic acid to the culture product, further continuing the culture, harvesting the cultured cells, and subsequently extracting the harvested cells with a solvent.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、植物の細胞培養技
術による新規なパラアミノ安息香酸配糖体とその製造方
法に関する。 本発明はまた、このパラアミノ安息香酸
配糖体を利用した医薬品または化粧品等の製剤に関す
る。
TECHNICAL FIELD The present invention relates to a novel para-aminobenzoic acid glycoside by a plant cell culture technique and a method for producing the same. The present invention also relates to a pharmaceutical or cosmetic preparation using the para-aminobenzoic acid glycoside.

【0002】[0002]

【従来の技術】パラアミノ安息香酸は下記の構造を有す
る化合物であって、
2. Description of the Related Art Para-aminobenzoic acid is a compound having the following structure:

【0003】[0003]

【化3】 Embedded image

【0004】ビタミンB複合体の形でゴボウなどに含有
されており、紫外線吸収剤として化粧品などに配合使用
されている。
[0004] It is contained in burdock and the like in the form of a vitamin B complex, and is used in cosmetics and the like as an ultraviolet absorber.

【0005】よく知られているように、太陽光線中の紫
外線のうちとくに290〜320nmの領域(いわゆる
「UVB」光)が、生物に対する作用が直接的であっ
て、刺激による皮膚の紅斑、水泡形成等の炎症をひきお
こし、色素の形成、皮膚の老化をもたらすほか、慢性的
曝露によるDNAの損傷や皮膚ガンの発生を招く。 従
って、UVB領域の紫外線を吸収して紫外線が原因とな
る上記の諸障害を防ぐ、紫外線防御剤の開発が進められ
ている。
[0005] As is well known, ultraviolet rays in the sun's rays, particularly in the region of 290 to 320 nm (so-called "UVB" light), have a direct effect on living organisms, and cause erythema and blisters on the skin due to irritation. It causes inflammation such as formation, causes pigment formation and skin aging, and also causes DNA damage and skin cancer due to chronic exposure. Therefore, development of an ultraviolet ray protective agent that absorbs ultraviolet rays in the UVB region and prevents the above-mentioned obstacles caused by ultraviolet rays has been promoted.

【0006】パラアミノ安息香酸はUVB領域の紫外線
を効果的に吸収するため、紫外線吸収剤として用いられ
て来た。 しかし、分子中に2箇の高極性基が存在する
ため、水などの極性溶媒との間で顕著な溶媒効果が起
り、吸収極大波長が290nmより短波長側に移動する浅
色シフトが起って、紫外線吸収効果が低減してしまう。
従って、パラアミノ安息香酸の紫外線吸収剤としての利
用は、その使用態様が制約を受けていた。 また、パラ
アミノ安息香酸自体は水に難溶性であるため、その製剤
は剤型が限られ、たとえば水系の基質のものは製造でき
ないなど、パラアミノ安息香酸の利用範囲も限定されて
いるのが実情である。
[0006] Para-aminobenzoic acid has been used as an ultraviolet absorber because it effectively absorbs ultraviolet rays in the UVB region. However, due to the presence of two highly polar groups in the molecule, a remarkable solvent effect occurs with a polar solvent such as water, causing a shallow color shift in which the absorption maximum wavelength moves to a shorter wavelength side than 290 nm. As a result, the ultraviolet absorbing effect is reduced.
Therefore, use of para-aminobenzoic acid as an ultraviolet absorber has been restricted in its use form. In addition, since para-aminobenzoic acid itself is poorly soluble in water, its formulation is limited, and the range of use of para-aminobenzoic acid is limited, for example, it is not possible to manufacture an aqueous substrate. is there.

【0007】[0007]

【発明が解決しようとする課題】本発明の目的は、ま
ず、パラアミノ安息香酸の利用に関して加えられていた
上記の制約を解消するひとつの手段として、パラアミノ
安息香酸を配糖体としたものを提供すること、それによ
って、水溶性をそなえるとともに溶媒に影響されること
なく紫外線吸収効果を発揮し得るパラアミノ安息香酸誘
導体を提供することにある。 次に、植物細胞培養技術
によるその製造方法を提供することにある。本発明の目
的には、このようにして得たパラアミノ安息香酸を有効
成分として含有する、医薬または化粧品のような、種々
の製剤を提供することも含まれる。
SUMMARY OF THE INVENTION An object of the present invention is to provide, as one means for solving the above-mentioned restriction on the use of para-aminobenzoic acid, a method using para-aminobenzoic acid as a glycoside. Accordingly, it is an object of the present invention to provide a para-aminobenzoic acid derivative which has water solubility and can exhibit an ultraviolet absorbing effect without being affected by a solvent. Another object is to provide a method for producing the same by a plant cell culture technique. The object of the present invention includes providing various preparations, such as medicines or cosmetics, containing the thus obtained para-aminobenzoic acid as an active ingredient.

【0008】[0008]

【課題を解決するための手段】本発明のパラアミノ安息
香酸配糖体は、下式Iの構造を有するモノ配糖体および
下式IIの構造を有するジ配糖体である。
The paraaminobenzoic acid glycoside of the present invention is a monoglycoside having the structure of the following formula I and a diglycoside having a structure of the following formula II.

【0009】[0009]

【化4】 Embedded image

【0010】[0010]

【化5】 Embedded image

【0011】〔式中、RはHまたはグルコース残基(1
→6)をあらわす。〕 上記の配糖体を与える本発明のパラアミノ安息香酸配糖
体の製造方法は、ユーカリ属(Eucalyptus)植物の組織
片から誘導した培養細胞を培養し、これにパラアミノ安
息香酸を添加してさらに培養を続けることにより変換を
行なわせ、培養した細胞を収穫し、溶剤抽出して変換生
成物である配糖体を得ることからなる。
Wherein R is H or a glucose residue (1
→ Represents 6). The method for producing a para-aminobenzoic acid glycoside of the present invention, which gives the above-mentioned glycoside, comprises culturing cultured cells derived from a tissue piece of a Eucalyptus plant, and adding para-aminobenzoic acid thereto. The conversion is performed by continuing the culture, and the cultured cells are harvested and extracted with a solvent to obtain a glycoside as a conversion product.

【0012】培地に添加されてユーカリ属植物の細胞に
付与されたパラアミノ安息香酸は、細胞内の配糖化酵素
のはたらきによって、パラアミノ安息香酸のカルボキシ
ル基にグルコース1位のOH基がエステル結合した、グ
ルコース1箇を主体としたモノ配糖体すなわち式(I)の
化合物となる。 続いて、パラアミノ安息香酸のアミノ
基にグルコースの1位が結合すれば、式(II)のジ配糖体
が形成される。
Paraaminobenzoic acid added to the culture medium and given to the cells of the plant of the genus Eucalyptus is characterized in that an OH group at the 1-position of glucose is ester-linked to the carboxyl group of paraaminobenzoic acid by the action of intracellular glycosylase. It becomes a monoglycoside composed mainly of one glucose, that is, the compound of the formula (I). Subsequently, when the 1-position of glucose is bonded to the amino group of para-aminobenzoic acid, a diglycoside of the formula (II) is formed.

【0013】[0013]

【発明の実施形態】細胞培養の諸条件、および溶剤抽出
によるパラアミノ安息香酸配糖体の回収操作の条件は、
この分野において既知の技術に従って、また後記する実
施例を参考にして、当業者は容易に決定し得るであろ
う。 式(I)のモノ配糖体と式(II)のジ配糖体とは、水
溶性の程度に若干の差があるため、前者はたとえば水−
メタノール混合溶媒により、また後者は水により抽出さ
れ分離できる。
BEST MODE FOR CARRYING OUT THE INVENTION The conditions for cell culture and the conditions for recovering para-aminobenzoic acid glycoside by solvent extraction are as follows:
Those skilled in the art will readily be able to determine this according to techniques known in the art and with reference to the examples that follow. Since the monoglycoside of the formula (I) and the diglycoside of the formula (II) have a slight difference in the degree of water solubility, the former is, for example, water-soluble.
It can be separated and extracted with a mixed solvent of methanol and the latter with water.

【0014】ユーカリ属植物としては、E.perriniana
(ツキヌキユーカリ)、E.globulus(ユーカリノキ)、
E.calophyllaE.radiataE.divesE.citrio
dora(レモンユーカリ)および E.polybractea からえ
らんだものを使用するのが好ましい。
[0014] as eucalyptus plant of the genus, E. perriniana
(Tsuki-nuki eucalyptus), E. globulus (eucalyptus),
E. FIG. calophylla , E. radiata , E. dives , E. citrio
dora (lemon eucalyptus) and E. It is preferable to use those selected from polybractea .

【0015】パラアミノ安息香酸を添加する培地は任意
であるが、MS(ムラシゲ/スクーグ)培地、LS(リ
ンスマイヤー/スクーグ)培地、、ガンボーグ(Gambo
rg)B5培地、ニッチ(Nitsch & Nitsch)培地、ホ
ワイト(White)培地またはこれらの改良培地が好適で
ある。
The medium to which para-aminobenzoic acid is added is optional, but may be any of MS (Murashige / Skoog) medium, LS (Rinsmeyer / Skoog) medium, and Gambog (Gambog) medium.
rg) B5 medium, niche (Nitsch & Nitsch) medium, White medium or their modified medium are suitable.

【0016】[0016]

【実施例】E.perriniana(ツキヌキユーカリ)の無菌
芽生えから、常法に従って培養細胞を誘導した。 それ
をさらに寒天培地にとり、25℃に保った暗所に静置
し、3〜4週間ごとに継代培養して成長のよい細胞株を
得た。
[Example] E. Cultured cells were derived from aseptic seedlings of perriniana ( Papula persica ) in a conventional manner. The cells were further placed on an agar medium, allowed to stand in a dark place kept at 25 ° C, and subcultured every 3 to 4 weeks to obtain a cell line with good growth.

【0017】寒天培地は、下記の組成をもつMS培地に
対して寒天0.9%、ベンジルアデニン1ppm およびシ
ュクロース3%(w/v)を添加して加熱溶解後、容量
100mlの三角フラスコに40mlずつ分注し、オートク
レーブ滅菌後、固化することにより用意したものであ
る。
The agar medium is prepared by adding 0.9% of agar, 1 ppm of benzyladenine and 3% (w / v) of agar to an MS medium having the following composition and dissolving by heating. It was prepared by dispensing 40 ml each, autoclaving and then solidifying.

【0018】 成分 含有量(mg/l) NH4NO3 1650 KNO3 1900 KH2PO4 170 H3BO3 6.2 MnSO4・4H2O 22.3 ZnSO4・4H2O 8.6 KI 0.83 Na2MoO4・2H2O 0.25 CoCl2・6H2O 0.025 CuSO4・5H2O 0.025 CaCl2・2H2O 440 MnSO4・7H2O 370 FeSO4・7H2O 27.8 Na2−EDTA 37.3 イノシトール 100 チアミン塩酸塩 0.1 ニコチン酸 0.5 ピリドキシリ塩酸塩 0.5 グリシン 2 配糖体製造のための細胞培養は、1ppm のベンジルアデ
ニンを含むMS改変培地約250mlを容量500mlの三
角フラスコに注入し、上記のツキヌキユーカリ培養細胞
を三角フラスコ1本あたり約30gずつ入れ、25℃に
保った暗所で3週間、回転培養することにより行なっ
た。
[0018] Component amount (mg / l) NH 4 NO 3 1650 KNO 3 1900 KH 2 PO 4 170 H 3 BO 3 6.2 MnSO 4 · 4H 2 O 22.3 ZnSO 4 · 4H 2 O 8.6 KI 0.83 Na 2 MoO 4 .2H 2 O 0.25 CoCl 2 .6H 2 O 0.025 CuSO 4 .5H 2 O 0.025 CaCl 2 .2H 2 O 440 MnSO 4 .7H 2 O 370 FeSO 4 .7H 2 O 27.8 Na 2 -EDTA 37.3 Inositol 100 Thiamine hydrochloride 0.1 Nicotinic acid 0.5 Pyridoxyli hydrochloride 0.5 Glycine 2 Cell cultures for the production of glycosides contain 1 ppm of benzyladenine About 250 ml of the MS modified medium is poured into a 500-ml Erlenmeyer flask, and about 30 g of the above-mentioned cultivated Tsukinuki eucalyptus cells are added to each Erlenmeyer flask. This was performed by rotating culture in a dark place for 3 weeks.

【0019】その後、三角フラスコ1本あたり25mgの
パラアミノ安息香酸を、エタノール溶液として無菌的に
投与した。
Thereafter, 25 mg of para-aminobenzoic acid per aseptic flask was aseptically administered as an ethanol solution.

【0020】さらに1週間回転培養を続けたのち、細胞
を収穫して培地から分けた。 培地をまずイオン交換樹
脂「ダイヤイオンHP−20」のカラムを通して培地成
分を吸着させたのち、カラムを水洗し、メタノール溶出
を行ない、メタノール溶媒を減圧下に留去してメタノー
ル溶出分画を得た。
After a further week of rotation culture, the cells were harvested and separated from the medium. After the medium is first adsorbed to the medium through a column of ion exchange resin "Diaion HP-20", the column is washed with water, methanol is eluted, and the methanol solvent is distilled off under reduced pressure to obtain a methanol eluted fraction. Was.

【0021】細胞はホモジナイズ後、メタノール冷浸を
行なって抽出エキスを得た。 このメタノールエキスを
水に溶解し、ジエチルエーテルで抽出した。 水層をさ
らに酢酸エチルで抽出し、残った水層を「ダイヤイオン
HP−20」のカラムに通して吸着させた。 カラムを
水洗後、20%のメタノールを含有する水−メタノール
混合溶媒で溶出し、20%メタノール溶出分画と水溶出
分画とに分けた。 ジエチルエーテル層と酢酸エチル層
は、減圧下に溶媒を留去した。
After the cells were homogenized, they were subjected to methanol cold soaking to obtain an extract. This methanol extract was dissolved in water and extracted with diethyl ether. The aqueous layer was further extracted with ethyl acetate, and the remaining aqueous layer was passed through a column of "Diaion HP-20" to be adsorbed. After washing the column with water, the column was eluted with a water-methanol mixed solvent containing 20% methanol, and separated into a 20% methanol elution fraction and a water elution fraction. The solvent was distilled off from the diethyl ether layer and the ethyl acetate layer under reduced pressure.

【0022】以上の操作を、操作系統図として図1に示
す。
The above operation is shown in FIG. 1 as an operation system diagram.

【0023】変換生成物を薄層クロマトグラフィーによ
り確認した後、シリカゲルクロマトグラフィーおよびH
PLCを用いて精製し、パラアミノ安息香酸モノ配糖体
(I)およびジ配糖体(II)を得た。 結果は下記のとおり
である: 細胞重量 成長率 投与量 配 糖 体 量 変換率 310gFW 3倍 150mg (I) 18.9mgDW 12.6% (II) 15.7mgDW 10.4% パラアミノ安息香酸モノ配糖体(I)の特性を下に示す。
After confirming the conversion product by thin layer chromatography, silica gel chromatography and H
Purified using PLC, para-aminobenzoic acid monoglycoside
(I) and diglycoside (II) were obtained. The results are as follows: Cell weight Growth rate Dose Glycoside amount Conversion rate 310 gFW 3 times 150 mg (I) 18.9 mgDW 12.6% (II) 15.7 mgDW 10.4% Paraaminobenzoic acid monoglycoside The properties of body (I) are shown below.

【0024】(I) パラアミノベンゾイル β−D−グ
ルコピラノサイド UV λmax(EtOH)nm 224.0,295.5 FAB−MS m/z 300〔M+H〕+ ,138
〔MH−Glc〕+ 1 H−NMR (CD3OD) δppm (Hz) 3.39〜3.45(2H,m,=7.0,H−4′a
nd 5′) 3.45〜3.51(2H,m,=7.0,H−2′a
nd 3′) 3.69(1H,dd,=12.0,5.0,H−6′
a) 3.85(1H,dd,=12.0,2.0,H−6′
b) 5.65(1H,d,=8.0,H−1′) 6.63(2H,d,=9.0,H−4 and 6) 7.81(2H,d,=9.0,H−3 and 7)。
(I) para-aminobenzoyl β-D-glucopyranoside UV λmax (EtOH) nm 224.0, 295.5 FAB-MS m / z 300 [M + H] + , 138
[MH-Glc] + 1 H-NMR (CD 3 OD) δppm J (Hz) 3.39~3.45 (2H, m, J = 7.0, H-4'a
nd 5 ') 3.45 to 3.51 (2H, m, J = 7.0, H-2'a
nd 3 ') 3.69 (1H, dd, J = 12.0, 5.0, H-6'
a) 3.85 (1H, dd, J = 12.0, 2.0, H-6 '
b) 5.65 (1H, d, J = 8.0, H-1 ') 6.63 (2H, d, J = 9.0, H-4 and 6) 7.81 (2H, d, J) = 9.0, H-3 and 7).

【0025】パラアミノ安息香酸ジ配糖体(II)の特性を
下に示す。
The properties of paraaminobenzoic acid diglycoside (II) are shown below.

【0026】(II) パラ(N−β−D−グルコピラノシル
アミノ)ベンゾイル β−D−グルコピラノサイド UV λmax(EtOH)nm 224.0,295.7 FAB−MS m/z 484〔M+Na〕+ ,462
〔M+H〕+ 1 H−NMR (CD3OD) δppm (Hz) 3.36(1H,dd,=8.0,8.0,H−2″) 3.47(1H,dd,=8.0,8.0,H−2´) 3.35〜3.50(6H,m,H−4′and 5′) 3.45〜3.51(2H,m,=7.0,H−
3′,4′,5′and3″,4″,5″) 3.67(1H,dd,=12.0,5.0,H−6′
a or 6″a) 3.70(1H,dd,=12.0,5.0,H−6′
a or 6″a) 3.86(1H,dd,=12.0,2.0,H−6′
b or 6″b) 4.63(1H,d,=8.0,H−1″) 5.66(1H,d,=8.0,H−1′) 6.81(2H,d,=9.0,H−4 and 6) 7.90(2H,d,=9.0,H−3 and 7)。
(II) para (N-β-D-glucopyranosylamino) benzoyl β-D-glucopyranoside UV λmax (EtOH) nm 224.0, 295.7 FAB-MS m / z 484 [ M + Na] + , 462
[M + H] + 1 H-NMR (CD 3 OD) δppm J (Hz) 3.36 (1H, dd, J = 8.0,8.0, H-2 ") 3.47 (1H, dd, J = 8.0, 8.0, H-2 ') 3.35 to 3.50 (6H, m, H-4' and 5 ') 3.45 to 3.51 (2H, m, J = 7. 0, H-
3 ', 4', 5 'and 3 ", 4", 5 ") 3.67 (1H, dd, J = 12.0, 5.0, H-6'
a or 6 "a) 3.70 (1H, dd, J = 12.0, 5.0, H-6 '
a or 6 "a) 3.86 (1H, dd, J = 12.0, 2.0, H-6 '
b or 6 "b) 4.63 (1H, d, J = 8.0, H-1") 5.66 (1H, d, J = 8.0, H-1 ') 6.81 (2H, d, J = 9.0, H-4 and 6) 7.90 (2H, d, J = 9.0, H-3 and 7).

【0027】上記2種の配糖体の 13CNMRスペクト
ルは、つぎのとおりである。
The 13 C NMR spectra of the two glycosides are as follows.

【0028】 化 合 物 (I) (II) ア グ リ コ ン 1 167.4 167.2 2 117.6 119.5 3 133.1 132.8 4 114.3 114.0 5 155.3 153.4 6 114.3 114.0 7 133.1 132.8 O−グルコース 1′ 95.8 95.9 2′ 74.1 74.1 3′ 78.2 78.2 4′ 71.2 71.2 5′ 78.8 78.8 6′ 62.4 62.4 N−グルコース 1″ 85.6 2″ 74.5 3″ 78.6 4″ 71.7 5″ 79.2 6″ 62.7 Compounds (I) (II) Agricone 1 167.4 167.2 2 117.6 119.5 3 133.1 132.8 4 114.3 114.0 5 155.3 153 .46 114.3 114.0 7133.1 132.8 O-glucose 1 '95.8 95.9 2' 74.1 74.1 3 '78.2 78.2 4' 71.2 71. 25 '78.8 78.8 6' 62.4 62.4 N-glucose 1 "85.6 2" 74.5 3 "78.6 4" 71.7 5 "79.2 6" 62.7

【0029】[0029]

【発明の効果】本発明により、植物細胞培養技術を利用
して、新規物質であるパラアミノ安息香酸の配糖体が、
複雑な合成工程を経る必要なく取得できる。 配糖体は
水溶性を示すから、パラアミノ安息香酸を有効成分とす
る種々の製剤において、水性基質を使用した製剤を含
め、種々の製剤形態が可能となる。 一方、配糖体とす
ることにより水の溶媒和がもたらす紫外線の吸収極大波
長の浅色シフトが防げるから、パラアミノ安息香酸の紫
外線吸収効果を十分に利用することができる。
Industrial Applicability According to the present invention, a novel substance, a glycoside of paraaminobenzoic acid, is obtained by utilizing a plant cell culture technique.
It can be obtained without having to go through complicated synthesis steps. Glycosides are water-soluble, so that various formulations containing para-aminobenzoic acid as an active ingredient, including those using an aqueous substrate, can be made into various formulations. On the other hand, the use of glycosides can prevent the ultraviolet absorption maximum wavelength from being shifted by the solvation of water into a shallow color, so that the ultraviolet absorption effect of para-aminobenzoic acid can be sufficiently utilized.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 本発明の方法に従うパラアミノ安息香酸配糖
体の製造において、パラアミノ安息香酸の投与後の細胞
培養物の処理操作を示す操作系統図。
FIG. 1 is an operation system diagram showing a treatment operation of a cell culture after administration of para-aminobenzoic acid in the production of para-aminobenzoic acid glycoside according to the method of the present invention.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C09K 3/00 104 C09K 3/00 104Z C12N 5/04 C12N 5/00 F (C12P 19/44 C12R 1:91) (C12N 5/04 C12R 1:91) ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification symbol FI C09K 3/00 104 C09K 3/00 104Z C12N 5/04 C12N 5/00 F (C12P 19/44 C12R 1:91) (C12N 5 / 04 C12R 1:91)

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 下式IまたはIIであらわされるパラアミ
ノ安息香酸配糖体: 【化1】 【化2】 〔式中、RはHまたはグルコース残基(1→6)をあら
わす。〕
1. A para-aminobenzoic acid glycoside represented by the following formula I or II: Embedded image [Wherein, R represents H or a glucose residue (1 → 6). ]
【請求項2】 ユーカリ属(Eucalyptus )植物の組織
片から誘導した培養細胞を培養し、これにパラアミノ安
息香酸を添加してさらに培養を続けることにより変換を
行なわせ、培養した細胞を収穫し、溶剤抽出して変換生
成物である配糖体を得ることからなるパラアミノ安息香
酸配糖体の製造方法。
2. A culturing a eucalyptus (Eucalyptus) cultured cells derived from the tissue pieces of plants, this was done to transform by continuing further culture by adding para-aminobenzoic acid, and harvested cultured cells, A method for producing a para-aminobenzoic acid glycoside, comprising obtaining a glycoside as a conversion product by solvent extraction.
【請求項3】 ユーカリ属植物として、E.perriniana
(ツキヌキユーカリ)、E.globulus(ユーカリノキ)、
E.calophyllaE.radiataE.divesE.citrio
dora(レモンユーカリ)およびE.polybractea からえ
らんだものを使用する請求項2の製造方法。
3. A plant belonging to the genus Eucalyptus, E. coli . perriniana
(Tsuki-nuki eucalyptus), E. globulus (eucalyptus),
E. FIG. calophylla , E. radiata , E. dives , E. citrio
dora (lemon eucalyptus) and E. 3. The method according to claim 2, wherein a substance selected from polybractea is used.
【請求項4】 パラアミノ安息香酸を添加する培地とし
て、MS(ムラシゲ/スクーグ)培地、LS(リンスマ
イヤー/スクーグ)培地、ガンボーグ(Gamborg)BS
培地、ニッチ(Nitsch & Nitsch)培地、ホワイト
(White)培地またはこれらの改良培地を使用して実施
する請求項2の製造方法。
4. A medium to which para-aminobenzoic acid is added, MS (Murasige / Skoog) medium, LS (Rinsmeyer / Skoog) medium, Gamborg BS
3. The method according to claim 2, wherein the method is carried out using a medium, a niche (Nitsch & Nitsch) medium, a white medium, or an improved medium thereof.
【請求項5】 請求項1に記載のパラアミノ安息香酸配
糖体を有効成分として含有する製剤。
5. A preparation containing the para-aminobenzoic acid glycoside according to claim 1 as an active ingredient.
【請求項6】 水系の基質を使用した請求項5の製剤。6. The preparation according to claim 5, wherein an aqueous substrate is used.
JP8333465A 1996-12-13 1996-12-13 Para-aminobenzoic acid glycoside, its production and preparation containing the same as active ingredient Pending JPH10175989A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8333465A JPH10175989A (en) 1996-12-13 1996-12-13 Para-aminobenzoic acid glycoside, its production and preparation containing the same as active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8333465A JPH10175989A (en) 1996-12-13 1996-12-13 Para-aminobenzoic acid glycoside, its production and preparation containing the same as active ingredient

Publications (1)

Publication Number Publication Date
JPH10175989A true JPH10175989A (en) 1998-06-30

Family

ID=18266389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8333465A Pending JPH10175989A (en) 1996-12-13 1996-12-13 Para-aminobenzoic acid glycoside, its production and preparation containing the same as active ingredient

Country Status (1)

Country Link
JP (1) JPH10175989A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049583A1 (en) * 1999-12-30 2001-07-12 Kim Jong Ki An opening and closing device of closure receptacle for fluid
JP2006180875A (en) * 2004-12-02 2006-07-13 Ezaki Glico Co Ltd Transglucosylation method to carboxy group

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049583A1 (en) * 1999-12-30 2001-07-12 Kim Jong Ki An opening and closing device of closure receptacle for fluid
JP2006180875A (en) * 2004-12-02 2006-07-13 Ezaki Glico Co Ltd Transglucosylation method to carboxy group

Similar Documents

Publication Publication Date Title
EP0811595B1 (en) Hydrochalcone derivatives, comestic compositions containing the same, and processes for the preparation of both
DE19524515A1 (en) Saccharide conjugates
JPH03227913A (en) Hair dye and cosmetic for hair
CN106459122B (en) For the preservation of biomaterial and microorganism and the glycopeptide derivatives of protection
JP2021505643A (en) Extract of above-ground part of Shikouka and its manufacturing method
JPH10175989A (en) Para-aminobenzoic acid glycoside, its production and preparation containing the same as active ingredient
JP2001302525A (en) External preparation for skin care
Sun et al. Crystal and molecular structures of a natural equimolecular mixture of two epimeric diterpenes
JP3813733B2 (en) Cosmetics for preventing and improving wrinkles
EP2604605B1 (en) Theanine derivative, preparation method thereof, and use thereof for alleviating acne
DE2202690A1 (en) Process for the preparation of the antibiotics 20798 RP and 27706 RP, as well as the antibiotic 27706 RP and compositions containing it
WO2017170722A1 (en) Anti-inflammatory agent
JPS63440B2 (en)
JPH07215888A (en) Antityrosinase activity composition
WO2017170713A1 (en) Anti-photoaging agent
JP4402278B2 (en) Whitening cosmetics
JPH06128566A (en) Photooxidation inhibitor and dermal preparation containing same
JP3765779B2 (en) Skin preparation for preventing pigmentation
JP2001302655A (en) New substance isolated from ecklonia cava, method for extracting and purifying the new substance and method for using the new substance as antioxidant
JPH10152443A (en) Treatment and stabilization of plant extract
JP2000239266A (en) New polyene-based antibiotic
US3505311A (en) Corrinoid compounds containing no metal
JP3967471B2 (en) Skin external preparation suitable for whitening
JP4175740B2 (en) Melanin production inhibitor
JP3072267B2 (en) Hydrochalcone derivatives, cosmetics containing the derivatives, and methods for producing them